Prostate cancer Board decisions

The appeal for service connection of prostate cancer is remanded. The VA will obtain missing medical records and a new medical opinion.

The Board denied the veteran's motion to revise or reverse a previous decision that did not grant service connection for loss of sphincter control. The Board found no clear and unmistakable error in the original decision.

The Board granted the Veteran's appeal, finding that the severance of service connection for bladder cancer, prostate cancer, kidney disease, scars, and hypertension was improper. The Board also granted the appeal for the severance of Special Monthly Compensation (SMC) based on statutory housebound and Dependents' Educational Assistance (DEA).

The veteran's request for a higher disability rating for prostate cancer residuals was denied. The appeal for special monthly compensation based on housebound criteria was dismissed as moot.

The Board denied the veteran's claim for special monthly compensation based on the need for regular aid and attendance or at the housebound rate. The decision was based on the lack of evidence showing that the service-connected disabilities rendered the veteran helpless enough to require regular aid and attendance.

The veteran is granted an initial rating of 40 percent for residuals from prostate cancer with voiding dysfunction. The claim for service connection for a heart condition, including atrial fibrillation with valvular heart disease and cardiomyopathy, is remanded.

The veteran's effective date for service connection of tinnitus and prostate cancer was moved to January 19, 2021. Other issues were remanded.

The veteran's claims for service connection for COPD, coronary artery disease, diabetes mellitus type II, residuals of prostate cancer, hypertension, and neuropathy of the lower extremities were denied. The claim for tinnitus was granted.

The Board denied service connection for prostate cancer because the evidence did not show a relationship between the Veteran's prostate cancer and his military service, including exposure to TCE.

The Board denied the veteran's appeal to restore his 100% disability rating for prostate cancer, confirming a 20% rating effective November 1, 2022.

The appeal is remanded to obtain missing VA treatment records and reassess the effective date for service-connected prostate cancer residuals.

The Board denied service connection for all claimed conditions, including hypertension, hypothyroidism, loss of vision in the left eye, prostate cancer, and metastatic bone cancer. The decision was based on a lack of evidence linking these conditions to military service.

The veteran's effective date for service connection of prostate cancer is granted as July 19, 2022.

The veteran's service connection for non-Hodgkin's lymphoma, prostate cancer, and diabetes mellitus is granted under the PACT Act due to presumed exposure to herbicide agents during service at a Royal Thai Airforce Base.

The appeal for service connection of prostate cancer is remanded. The Board needs more information on the Veteran's exposure to lead paint and its potential link to prostate cancer.

The veteran's service connection for several conditions, including prostate cancer and depression, was granted an effective date of September 13, 2021. Some rating evaluations were denied or granted at specific percentages.

The veteran's appeal for service connection of prostate cancer is granted under the PACT Act due to presumed exposure to burn pits during service in Kuwait and Iraq.

The veteran was granted a 60% rating for prostate cancer and TDIU, but denied an increased rating for PTSD. The veteran was also granted SMC based on being housebound.

The Board remanded the claim to obtain a medical opinion on whether the Veteran's service-connected prostate cancer contributed to his death.

The veteran's claim for erectile dysfunction and special monthly compensation was granted effective February 24, 2020. The appeals regarding proposed rating reductions were dismissed.